• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Crit Care . The impact of timing of initiating invasive mechanical ventilation in COVID-19-related respiratory failure

tetano

Editor, Senior Moderator
J Crit Care


. 2023 May 8;77:154322.
doi: 10.1016/j.jcrc.2023.154322. Online ahead of print. The impact of timing of initiating invasive mechanical ventilation in COVID-19-related respiratory failure

Laura C Myers[SUP] 1 [/SUP], Patricia Kipnis[SUP] 2 [/SUP], John D Greene[SUP] 2 [/SUP], Aiyu Chen[SUP] 3 [/SUP], Beth Creekmur[SUP] 3 [/SUP], Stan Xu[SUP] 3 [/SUP], Viji Sankar[SUP] 4 [/SUP], Nareg H Roubinian[SUP] 2 [/SUP], Annette Langer-Gould[SUP] 5 [/SUP], Michael K Gould[SUP] 6 [/SUP], Vincent X Liu[SUP] 2 [/SUP]



Affiliations
Abstract

Purpose: Optimal timing of initiating invasive mechanical ventilation (IMV) in coronavirus disease 2019 (COVID-19)-related respiratory failure is unclear. We hypothesized that a strategy of IMV as opposed to continuing high flow oxygen or non-invasive mechanical ventilation each day after reaching a high FiO2 threshold would be associated with worse in-hospital mortality.
Methods: Using data from Kaiser Permanente Northern/Southern California's 36 medical centers, we identified patients with COVID-19-related acute respiratory failure who reached ≥80% FiO2 on high flow nasal cannula or non-invasive ventilation. Exposure was IMV initiation each day after reaching high FiO2 threshold (T[SUB]0[/SUB]). We developed propensity scores with overlap weighting for receipt of IMV each day adjusting for confounders. We reported relative risk of inpatient death with 95% Confidence Interval.
Results: Of 28,035 hospitalizations representing 21,175 patient-days, 5758 patients were included (2793 received and 2965 did not receive IMV). Patients receiving IMV had higher unadjusted mortality (63.6% versus 18.2%, P < 0.0001). On each day after reaching T[SUB]0[/SUB] through day >10, the adjusted relative risk was higher for those receiving IMV compared to those not receiving IMV (Relative Risk>1).
Conclusions: Initiation of IMV on each day after patients reach high FiO2 threshold was associated with higher inpatient mortality after adjusting for time-varying confounders. Remaining on high flow nasal cannula or non-invasive ventilation does not appear to be harmful compared to IMV. Prospective evaluation is needed.

Keywords: Coronavirus disease 2019; High flow nasal cannula; Invasive mechanical ventilation; Respiratory failure.

 
Back
Top Bottom